ICLR LEGAL DEADLINE: ICON plc Investors that Lost Money are Reminded of Pending Class Action – Contact BFA Law by April 11 Court Deadline (NASDAQ:ICLR)
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain of its senior executives for potential violations of the federal securities laws.
If you invested in ICON, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/icon-plc.
Investors have until April 11, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased ICON securities. The case is pending in the U.S. District Court for the Eastern District of New York and is captioned Shing v. ICON plc, et al., No. 25-cv-00763.
Why was ICON Sued for Securities Fraud?
ICON is a clinical research organization ('CRO') that provides a range of services to help its pharmaceutical company customers bring new drugs to market. In recent years, many large pharmaceutical companies have implemented drastic cost reduction programs, including shifting part of their clinical studies in-house and away from CROs like ICON.
Despite these industry trends, ICON repeatedly represented that client demand was robust and that the company was benefiting from the trends. However, in truth, ICON's business had significantly deteriorated due to customer cost reduction measures and industry funding limitations.
The Stock Declines as the Truth is Revealed
On October 23, 2024, ICON revealed a quarterly 'revenue shortfall' that missed analyst estimates by more than $100 million. The company also revealed that indicators of customer demand, such as net new business, had materially deteriorated, that two of its large pharmaceutical customers had significantly curtailed upcoming work, and that numerous other customers had cancelled, delayed, or reduced the scope of ongoing and planned trials. As a result, ICON cut its annual revenue guidance for 2024 by $220 million. This news caused a more than 20% decline in the price of ICON stock over a two-day trading period, from a closing price of $280.76 per share on October 23, 2024 to $220.47 per share on October 25, 2024.
Then, on January 14, 2025, ICON issued financial guidance for 2025 that came in well below analysts' expectations which the company attributed to the downturn in the industry. This news caused the price of ICON stock to decline more than 8%, from a closing price of $217.99 per share on January 13, 2025 to $200.24 per share on January 14, 2025.
Click here for more information: https://www.bfalaw.com/cases-investigations/icon-plc.
What Can You Do?
If you invested in ICON you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
Or contact:
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why Braze, Inc. (BRZE) Crashed On Friday
We recently published a list of . In this article, we are going to take a look at where Braze, Inc. (NASDAQ:BRZE) stands against other Friday's worst-performing stocks. Braze Inc. dropped its share prices by 17.65 percent on Friday to finish at $29.73 apiece as investors soured on its dismal earnings performance in the first quarter of fiscal year 2026. In a statement, Braze, Inc. (NASDAQ:BRZE) said attributable net loss was unchanged at $35 million, despite revenues increasing by 20 percent to $162 million from $135 million, driven primarily by new customers, upsells, and renewals. A web developer hunched over their laptop coding a customer engagement platform. For the second quarter of the year, Braze, Inc. (NASDAQ:BRZE) is targeting to hit $171 million to $172 million in revenues, with a net income ranging from $2.5 million to $3.5 million. The full-year period alone is expected to rake in between $702 million and $706 million in revenues, and a net income of $17 million to $21 million. The company also welcomed Ed McDonnell as its new chief revenue officer. 'McDonnell has a strong track record of delivering results at high-growth public SaaS businesses, and we believe his extensive background in Software and Customer Engagement will further solidify Braze as the leading customer engagement platform and accelerate growth in the coming years,' said Braze, Inc. (NASDAQ:BRZE) CEO Bill Magnuson. Overall, BRZE ranks 3rd on our list of Friday's worst-performing stocks. While we acknowledge the potential of BRZE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why DocuSign, Inc. (DOCU) Crashed On Friday
We recently published a list of . In this article, we are going to take a look at where DocuSign, Inc. (NASDAQ:DOCU) stands against other Friday's worst-performing stocks. DocuSign dropped its share prices by 18.97 percent on Friday to end at $75.28 apiece after slashing its full-year billing outlook amidst its shift to an artificial intelligence model. For the full year period, DocuSign, Inc. (NASDAQ:DOCU) now expects billings to settle in the range of $3.285 billion to $3.339 billion, down from its previous outlook of $3.30 billion to $3.354 billion. A software engineer in front of a computer screen, typing code to build the company's electronic signature software. According to DocuSign, Inc. (NASDAQ:DOCU) CEO Allan Thygesen, the decline in billings this year was expected due to 'foundational go-to-market changes' following the adoption of Intelligent Agreement Management, an AI-driven agreement platform. However, Thygesen said that 'the impact happened sooner than anticipated,' causing the drop in early renewals during the first quarter period, and negatively impacting billings growth. In the first quarter of the year, DocuSign, Inc. (NASDAQ:DOCU) achieved a 118-percent jump in net income to $72 million from $33 million in the same period last year. Revenues increased by 7.6 percent to $763 million from $709 million year-on-year. Overall, DOCU ranks 2nd on our list of Friday's worst-performing stocks. While we acknowledge the potential of DOCU as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
Why Lululemon Athletica Inc. (LULU) Crashed On Friday
We recently published a list of . In this article, we are going to take a look at where Lululemon Athletica Inc. (NASDAQ:LULU) stands against other Friday's worst-performing stocks. Lululemon fell by 19.8 percent on Friday to finish at $265.27 apiece following a disappointing earnings performance and outlook guidance for the rest of the year. In its financial statement, Lululemon Athletica Inc. (NASDAQ:LULU) said net income in the first quarter of the year dipped by 2 percent to $314 million from $321 million in the same period last year. Net revenues, on the other hand, grew by 7 percent to $2.37 billion from $2.2 billion year-on-year. A store employee in an athletic apparel store restocking merchandise. For the second quarter of the year, Lululemon Athletica Inc. (NASDAQ:LULU) expects net revenue to be in the range of $2.535 billion to $2.56 billion, representing growth of 7 percent to 8 percent. For the full-year period, it said targets net revenue to be in the range of $11.15 billion to $11.3 billion, representing growth of 5 to 7 percent. Following the guidance, JPMorgan and UBS both reduced their price targets for the company to $303 and $290, respectively, from $389 and $330 previously. Overall, LULU ranks 1st on our list of Friday's worst-performing stocks. While we acknowledge the potential of LULU as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
